Search for: "Abbott Nutrition" Results 201 - 220 of 243
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Sep 2015, 2:30 am by Thaddeus Mason Pope, J.D., Ph.D.
  TADA now exempts clinically assisted nutrition and hydration from the scope of life-sustaining treatment subject to Tex. [read post]
4 Feb 2015, 1:52 pm by Lawrence B. Ebert
In In re Cuozzo Speed Technologies, a split CAFC panel observedContrary to Cuozzo’s contention, we hold that we lackjurisdiction to review the PTO’s decision to institute IPR.We affirm the Board’s final determination, finding noerror in the Board’s claim construction under the broadestreasonable interpretation standard, the Board’s obviousnessdetermination, and the Board’s denial of Cuozzo’smotion to amend.The legal matter involved an inter partes review… [read post]
11 Dec 2013, 10:01 pm by Dan Flynn
Back then, the upscale South Korean woman who became pregnant was likely to choose the Abbott Laboratories product sold under the Similac brand because it was the choice of American women. [read post]
23 Jul 2013, 12:00 am
DuPont Nutrition Biosciences involved patent 7,713,723 directed toward recombinant Bacillus alpha-amylase enzymes engineered to have enhanced acid tolerance and heat tolerance. [read post]
15 May 2012, 7:31 am by Neal Fortin
The ACI’s Food Safety Regulatory Compliance Event on June 26 - 27, 2012, provides in-depth guidance from in-house peers in the food industry, Abbott Nutrition, Cargill, ConAgra, Herbalife, H.J. [read post]
3 Apr 2012, 11:00 am by Lucas A. Ferrara, Esq.
Abbott is the third largest U.S. pharmaceutical company. [read post]
22 Mar 2012, 4:24 pm
The applicable standard for claims under all three statutes was notice pleading under Rule 8(a).The purchasers alleged that Abbott misled consumers as to the safety of Similac through the following affirmative statements: (1) Similac is “safe for the consumption by infants”; (2) Abbott was “dedicated to the highest standards of manufacturing and marketing—and to complying with all applicable laws and regulations”; (3) Similac “provid[es] babies… [read post]
19 Mar 2012, 8:32 am by Rebecca Tushnet
Turning to the specific statements, plaintiffs identified four: (1) Similac was “safe for the consumption by infants”; (2) Abbott was “dedicated to the highest standards of manufacturing and marketing—and to complying with all applicable laws and regulations in the countries where [they] do business”; (3) Similac “provid[es] babies with excellent nutrition for growth and development and has been clinically proven to aid brain, bone and immune… [read post]
5 Dec 2011, 3:14 am by John L. Welch
The Board sustained Abbott's opposition to registration of CATSURE and DOGSURE for food supplements for cats and dogs, respectively, finding the marks likely to cause confusion with the registered mark ENSURE for nutritional products and supplements. [read post]
1 Sep 2011, 2:39 am by John L. Welch
September 22, 2011 - 2 PM: Abbott Laboratories v. [read post]
22 Jun 2011, 1:58 pm by Mark Zamora
The health care company Abbott says about 5 million containers of its Similac-brand powdered infant formulas—which includes Isomil and Go & Grow—are being recalled because of possible contamination with insect pieces or larvae.The voluntary recall affects milk- and soy-based formulas distributed in the United States, Puerto Rico, Guam, and some Caribbean nations. [read post]
26 Jan 2011, 9:52 am by Rebecca Tushnet
Lacey, Division Counsel, Abbott Laboratories I came in near the end, but Lacey emphasized that a marketer needs to know the difference between labeling (FDA authority) and other material (FTC)—if you detail to pediatricians about foods with nutritional benefits, for example, FDA largely prohibits nutrient claims for kids under 2. [read post]
7 Dec 2010, 2:43 am by Ben Vernia
They also included intravenously administered nutritional solutions and a variety of other intravenously administered drugs. [read post]
4 Nov 2010, 5:00 am by Kimberly A. Kralowec
Rafeedie of Jones, Bell, Abbott, Fleming & Fitzgerald LLP in Los Angeles argued for the defendant. [read post]
12 Oct 2010, 4:56 pm by rreeves
Last week, the Food and Drug Administration announced that it was recalling the anti-obesity drug Meridia, manufactured by Abbott Laboratories from the American market. [read post]
28 Sep 2010, 7:35 am by Mark Zamora
Products not involved in the recall include all Abbott Nutrition liquid ready-to-feed and concentrated infant formulas and all powder and liquid specialty formulas, such as Similac Expert Care™ Alimentum®, Elecare®, Similac Expert Care™ Neosure®, Similac® Human Milk Fortifier, and metabolic formulas for inherited disorders.About the RecallThe company is implementing a plan to address this matter in the affected manufacturing facility, which is… [read post]